Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Free Cash Flow: 2019-2024

Historic Free Cash Flow for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $9.3 million.

  • Mirum Pharmaceuticals' Free Cash Flow rose 938.50% to $39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.3 million, marking a year-over-year increase of 2116.29%. This contributed to the annual value of $9.3 million for FY2024, which is 113.13% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Free Cash Flow is $9.3 million, which was up 113.13% from -$71.1 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Free Cash Flow peaked at $9.3 million during FY2024, and registered a low of -$132.8 million during FY2021.
  • For the 3-year period, Mirum Pharmaceuticals' Free Cash Flow averaged around -$60.7 million, with its median value being -$71.1 million (2023).
  • In the last 5 years, Mirum Pharmaceuticals' Free Cash Flow tumbled by 125.26% in 2020 and then spiked by 113.13% in 2024.
  • Yearly analysis of 5 years shows Mirum Pharmaceuticals' Free Cash Flow stood at -$89.3 million in 2020, then crashed by 48.69% to -$132.8 million in 2021, then rose by 9.31% to -$120.4 million in 2022, then soared by 40.99% to -$71.1 million in 2023, then surged by 113.13% to $9.3 million in 2024.